Top oncology conference is coming! Multiple popular anti-cancer drugs will debut, involving these A-share companies.
①The annual meeting of the European Society for Medical Oncology will be held in Barcelona, Spain in 2024; ②At the meeting, Beigene, Jiangsu Hengrui Pharmaceuticals and other listed companies will release the latest data on their oncology drugs; ③In addition, the conference will also discuss cutting-edge topics such as the impact of artificial intelligence on the diagnosis and treatment of tumors.
Quick Look at Mid-day Trading | The three major stock indexes in Hong Kong all fell, with oil and coal stocks declining; all three major oil companies saw a drop of over 5%, while Tianqi Lithium Corporation surged 12% against the market trend.
Network technology stocks generally fell, with SenseTime down nearly 3%, JD.com, Netease down nearly 1%, Tencent, Alibaba slightly down; Bilibili rose by over 1%, Meituan slightly rose.
Another unreasonable suppression! The U.S. House of Representatives has passed the Biosecurity Act, and wuxi apptec and wuxi bio have quickly responded.
①The U.S. House of Representatives passed the draft of the Biosecurity Act (H.R.8333) with 306 votes in favor and 81 votes against. ②Wuxi Apptec, Wuxi Bio, and other companies strongly opposed it. ③This bill still needs to be voted on by the Senate and the versions passed by both houses need to be reconciled before it can be submitted to the U.S. President for signing into law.
Hainan offshore duty-free under pressure, China Tourism Group Duty Free Corporation's revenue and net profit both decrease, analysts say: limited impact from new tax-free policy in the city | Interpretations
①The china tourism group duty free corporation's H1 revenue decreased by 12.81% year-on-year, and the net income attributable to shareholders decreased by 15.07% year-on-year; ②Recently, several departments have issued a "Notice on Improving the Policy of Duty-free Shops in the City", while the Department of Commerce of Hainan Province has organized the distribution of "Air Ticket + Duty-free" consumer coupons; ③Analysts believe that the new policy of city duty-free shops has a limited impact on the duty-free market due to the narrow range of customer groups involved.
The decline in the pharmaceutical sector is affecting overall revenue. Fosun Pharma: Will focus on building super 1 billion yuan big varieties | Earnings conference highlights.
Fosun Pharma's revenue from innovative drugs in the first half of the year exceeded 3.7 billion yuan, accounting for about 18% of the overall revenue. Wu Yifang revealed that the business of innovative drugs will strive to achieve a compound annual growth rate of 30% in the next few years. Wu Yifang said that the privatization of Henlius is currently underway, and the entire business and pipeline of Henlius will be deeply integrated with Fosun Pharma through privatization.
beijing wantai biological pharmacy enterprise's application for the listing of the nine-valent HPV vaccine has been accepted, but the stock price is "handsome for only three seconds"?
① Beijing Wantai Biological Pharmacy Enterprise has received the acceptance notice from the Drug Evaluation Center of the National Medical Products Administration for the application of the marketing authorization of its nine-valent HPV vaccine. ② The stock price of Beijing Wantai Biological Pharmacy Enterprise rose sharply this afternoon, but quickly fell back. As of the close of today, the increase was 3.9%. ③ In addition, Beijing Wantai Biological Pharmacy Enterprise is still facing fierce competition from its rivals in the field of nine-valent HPV vaccines.